Top

Published in:

01-03-2022 | Glimepiride | Clinical study

Some sulfonylureas increase risk of MACE in patients with T2DM

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Cardiac mitochondrial ATP-sensitive potassium (mitoK_ATP) channel high-affinity sulfonylureas appear to increase the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus (T2DM) compared with low-affinity sulfonylureas, according to findings of a Taiwanese study published in Diabetes Care. …

Wang MT, et al. Association Between Specificity of Sulfonylureas to Cardiac Mitochondrial KATP Channels and the Risk of Major Adverse Cardiovascular Events in Type 2 Diabetes. Diabetes Care : 16 Mar 2022. Available from: URL: http://doi.org/10.2337/dc21-1779

Title: Some sulfonylureas increase risk of MACE in patients with T2DM
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Glimepiride
Stroke
Glibenclamide
Sulfonylurea
Glipizide
Gliclazide
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-11985-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Some sulfonylureas increase risk of MACE in patients with T2DM

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Metamfetamine

Enoxaparin-sodium

Sertraline

Antiparkinsonians

Epinephrine/vancomycin

Remdesivir